LENEXA, Kan.--(BUSINESS WIRE)--Aug 29, 2025--Eurofins Viracor BioPharma Services, a recognized leader in analytical testing and clinical trial services, announces the infrastructure enhancement of its headquarters and laboratory operations to a new, custom-built 96,000 sq. ft. facility in Lenexa, Kansas, scheduled for completion in September 2025. This strategic move, although only a few miles from its previous location, marks a significant milestone in the company’s continued growth and commitment to delivering cutting-edge solutions to the biopharmaceutical industry.Eurofins Viracor BioPharma Services was formally spun out of Eurofins Viracor in 2020 to focus exclusively on supporting biopharmaceutical sponsors with specialized analytical and clinical trial services.